An official website of the United States government
NIH Guide: Weekly Index for July 14, 2023
Weekly NIH Guide Notices
July 14, 2023
Policy Notices
-
Update - NIH Response to Registration Issues in SAM.gov
(NOT-OD-23-153)National Institutes of Health
-
Review Integrity and Bias Awareness Training will be Required for NIH Reviewers Effective May 2024 Council Round
(NOT-OD-23-156)National Institutes of Health
General Notices
-
Notice of NCCIH Technical Assistance Webinar and Teaming Webinar for RFA-AT-22-003 "HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)"
(NOT-AT-24-010)National Center for Complementary and Integrative Health
-
Notice of Prize Competition for the DataWorks! - NIH FASEB Challenge
(NOT-OD-23-151)Office of the Director, NIH
-
Request for Information (RFI): Inviting Input Regarding NIDCDs Research Directions to Support Communication in Minimally Verbal/Non-Speaking People
(NOT-DC-23-013)National Institute on Deafness and Other Communication Disorders
-
Request for Information (RFI): Infrastructure for Research in Nonhuman Primates
(NOT-OD-23-150)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Request for Information (RFI) on Flexibilities for Streamlining IACUC Review of Protocols and Significant Changes
(NOT-OD-23-152)Office of the Director, NIH
-
Request for Information (RFI) on an Update to the Current OLAW Guidance Disclaimer
(NOT-OD-23-157)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"
(NOT-CA-23-077)National Cancer Institute
-
Notice of Change to the Composition of the Advisory Committee in PAR-23-063 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)"
(NOT-GM-23-047)National Institute of General Medical Sciences
-
Notice of Expiration of NOT-GM-22-009 Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences
(NOT-GM-23-048)National Institute of General Medical Sciences
-
Notice of Corrected Application Forms for RFA-HG-22-027, Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
(NOT-HG-23-046)National Human Genome Research Institute
-
Notice of NINR Participation in PAR-23-166, Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
(NOT-NR-23-013)National Institute of Nursing Research
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed)
(NOT-MH-23-335)National Institute of Mental Health
-
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed)
(NOT-MH-23-336)National Institute of Mental Health
-
Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(NOT-NS-23-091)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthOffice of Behavioral and Social Sciences Research
-
Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(NOT-NS-23-093)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthOffice of Behavioral and Social Sciences Research
Notices of Special Interest
-
Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp)
(NOT-NS-23-092)National Institute of Neurological Disorders and StrokeNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Environmental Health SciencesNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and Bioengineering
Funding Opportunities
-
PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
(PA-23-230)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Center for Environmental HealthNational Center for Injury Prevention and ControlNational Institute for Occupational Safety and HealthNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational SciencesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
-
PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
(PA-23-231)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Center for Environmental HealthNational Center for Injury Prevention and ControlNational Institute for Occupational Safety and HealthNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
(PA-23-232)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational SciencesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
-
PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
(PA-23-233)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
(PAR-23-216)National Institute of General Medical SciencesApplication Receipt Date(s): Multiple dates, see announcement.
-
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
(PAR-23-219)Office of the Director, NIHNational Institute on Alcohol Abuse and AlcoholismNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Institute of Biomedical Imaging and BioengineeringNational Center for Advancing Translational SciencesApplication Receipt Date(s): Multiple dates, see announcement.
-
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
(PAR-23-220)Office of the Director, NIHNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Deafness and Other Communication DisordersNational Eye InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Research Resource for Systematic Reviews of Complementary and Integrative Health (R24 Clinical Trial Not Allowed)
(RFA-AT-24-005)National Center for Complementary and Integrative HealthApplication Receipt Date(s): August 31, 2023
-
Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)
(RFA-DK-22-512)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): October 19, 2023
-
Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-DK-22-513)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): October 19, 2023
-
Single Source: NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
(RFA-EB-23-007)National Institute of Biomedical Imaging and BioengineeringNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): September 26, 2023
-
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clinical Trial Not Allowed)
(RFA-HL-24-006)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): October 27, 2023
-
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
(RFA-HL-24-007)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): October 27, 2023
-
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)
(RFA-HL-24-012)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): October 27, 2023
-
Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)
(RFA-MH-24-150)National Institute of Mental HealthApplication Receipt Date(s): October 17, 2023
-
Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed)
(RFA-MH-24-151)National Institute of Mental HealthApplication Receipt Date(s): October 17, 2023
-
Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)
(RFA-RM-23-013)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): December 04, 2023
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster